Dr. Steven R. Goodman is the former VCR at UTHSC, where he currently serves as a tenured Professor of Pediatrics, with a joint appointment in Physiology. He earned a BS in Chemistry at SUNY Stony Brook, a PhD at St. Louis University Medical School, and did post-doctoral fellowships at Harvard Medical School and the Harvard BioLabs. Dr. Goodman has performed five decades of research into the structure and function of erythrocyte and nonerythroid spectrin membrane skeletons. We made the seminal discovery of nonerythroid spectrin. His research into sickle cell disease (SCD) led to breakthrough discoveries into the molecular basis of formation of irreversibly sickled cells. Over the last three decades he utilized proteomic technologies to define the normal erythrocyte proteome and its interactome, demonstrated the changes in this proteome in SCD, performed pharmaco-proteomic studies of the impact of drugs utilized in the treatment of SCD, and identified candidate biomarkers of sickle cell severity. His research in neuroscience led to the discovery of the brain spectrin isoforms, their sequence, location within neurons, and the role of one brain spectrin isoform in synaptic transmission. These, and prior, research accomplishments have led to his being named as a Distinguished Scientist of the Society of Experimental Biology and Medicine in 2011 and an American Association for the Advancement of Science (AAAS) Fellow in 2016.